These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10562306)

  • 1. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.
    Smit JW; Huisman MT; van Tellingen O; Wiltshire HR; Schinkel AH
    J Clin Invest; 1999 Nov; 104(10):1441-7. PubMed ID: 10562306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance protein 2 is an important determinant of paclitaxel pharmacokinetics.
    Lagas JS; Vlaming ML; van Tellingen O; Wagenaar E; Jansen RS; Rosing H; Beijnen JH; Schinkel AH
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6125-32. PubMed ID: 17062689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.
    Washington CB; Wiltshire HR; Man M; Moy T; Harris SR; Worth E; Weigl P; Liang Z; Hall D; Marriott L; Blaschke TF
    Drug Metab Dispos; 2000 Sep; 28(9):1058-62. PubMed ID: 10950849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
    Mayer U; Wagenaar E; Dorobek B; Beijnen JH; Borst P; Schinkel AH
    J Clin Invest; 1997 Nov; 100(10):2430-6. PubMed ID: 9366556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro to in vivo comparison of the substrate characteristics of sorafenib tosylate toward P-glycoprotein.
    Gnoth MJ; Sandmann S; Engel K; Radtke M
    Drug Metab Dispos; 2010 Aug; 38(8):1341-6. PubMed ID: 20413726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of P-glycoprotein in the human blood-placental barrier.
    Mölsä M; Heikkinen T; Hakkola J; Hakala K; Wallerman O; Wadelius M; Wadelius C; Laine K
    Clin Pharmacol Ther; 2005 Aug; 78(2):123-31. PubMed ID: 16084847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice.
    Manford F; Riffo-Vasquez Y; Spina D; Page CP; Hutt AJ; Moore V; Johansson F; Forbes B
    J Pharm Pharmacol; 2008 Oct; 60(10):1305-10. PubMed ID: 18812023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
    Schinkel AH; Mayer U; Wagenaar E; Mol CA; van Deemter L; Smit JJ; van der Valk MA; Voordouw AC; Spits H; van Tellingen O; Zijlmans JM; Fibbe WE; Borst P
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4028-33. PubMed ID: 9108099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
    Schinkel AH; Wagenaar E; van Deemter L; Mol CA; Borst P
    J Clin Invest; 1995 Oct; 96(4):1698-705. PubMed ID: 7560060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes.
    Schuetz EG; Umbenhauer DR; Yasuda K; Brimer C; Nguyen L; Relling MV; Schuetz JD; Schinkel AH
    Mol Pharmacol; 2000 Jan; 57(1):188-97. PubMed ID: 10617694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
    Schinkel AH; Wagenaar E; Mol CA; van Deemter L
    J Clin Invest; 1996 Jun; 97(11):2517-24. PubMed ID: 8647944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.
    van Waterschoot RA; Lagas JS; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Song JY; Rooswinkel RW; van Tellingen O; Rosing H; Beijnen JH; Schinkel AH
    Cancer Res; 2009 Dec; 69(23):8996-9002. PubMed ID: 19920203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein.
    Bonhomme-Faivre L; Benyamina A; Reynaud M; Farinotti R; Abbara C
    Addict Biol; 2008 Sep; 13(3-4):295-300. PubMed ID: 18331373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta.
    Rahi M; Heikkinen T; Hakkola J; Hakala K; Wallerman O; Wadelius M; Wadelius C; Laine K
    Hum Exp Toxicol; 2008 Jan; 27(1):65-71. PubMed ID: 18480151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception.
    Kalvass JC; Olson ER; Pollack GM
    Drug Metab Dispos; 2007 Mar; 35(3):455-9. PubMed ID: 17178769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice.
    Salama NN; Kelly EJ; Bui T; Ho RJ
    J Pharm Sci; 2005 Jun; 94(6):1216-25. PubMed ID: 15858856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography.
    Hendrikse NH; Schinkel AH; de Vries EG; Fluks E; Van der Graaf WT; Willemsen AT; Vaalburg W; Franssen EJ
    Br J Pharmacol; 1998 Aug; 124(7):1413-8. PubMed ID: 9723952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential involvement of multidrug resistance-associated protein 1 and P-glycoprotein in tissue distribution and excretion of grepafloxacin in mice.
    Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
    J Pharmacol Exp Ther; 2004 Aug; 310(2):648-55. PubMed ID: 15131241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice.
    Press RR; Buckle T; Beijnen JH; van Tellingen O
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):819-25. PubMed ID: 16163538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted.
    Smit JW; Schinkel AH; Weert B; Meijer DK
    Br J Pharmacol; 1998 May; 124(2):416-24. PubMed ID: 9641561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.